SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹474 Cr | ₹414 Cr | ₹343 Cr | ₹369 Cr | ₹327 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹474 Cr |
| Mar2024 | ₹414 Cr |
| Mar2023 | ₹343 Cr |
| Mar2022 | ₹369 Cr |
| Mar2021 | ₹327 Cr |
How is Long Term Provisions of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹474 Cr | 14.47 | |
| Mar2024 | ₹414 Cr | 20.70 | |
| Mar2023 | ₹343 Cr | -7.09 | |
| Mar2022 | ₹369 Cr | 12.82 | |
| Mar2021 | ₹327 Cr | - | |
Compare Long Term Provisions of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,917.6 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
| MANKIND PHARMA | ₹105,169.0 Cr | 0.7% | 7.1% | 8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.3% |
3.4% |
12.7% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses